Paul Corn, MD
M.D. Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Paul Corn, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:54 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT01994590 · Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)M.D. Anderson Cancer Center · terminated · Prostate Cancer · principal investigator
- Ph2NCT01630590 · Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate CancerM.D. Anderson Cancer Center · completed · Prostate Cancer · principal investigator
- Ph2NCT01254864 · Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted TherapiesM.D. Anderson Cancer Center · completed · Prostate Cancer · principal investigator
- Ph2NCT00831792 · TKI258 in Castrate Resistant Prostate CancerM.D. Anderson Cancer Center · completed · Prostate Cancer · principal investigator
- Ph1NCT00631527 · Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate CancerM.D. Anderson Cancer Center · completed · Prostate Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.